Label: SENNA LAXATIVE- sennosides tablet

  • NDC Code(s): 70677-0164-1
  • Packager: Strategic Sourcing Services LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 19, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Sennosides 8.6 mg

  • Purpose

    Laxative

  • Uses

    • relieves occasional constipation (irregularity)
    • generally produces bowel movement in 6-12 hours
  • Warnings

    Do not use

    • laxative products for longer than 1 week unless directed by a doctor

    Ask a doctor before use if you have

    • stomach pain
    • nausea
    • vomiting
    • noticed a sudden change in bowel habits that continues over a periodof 2 weeks 

    Stop use and ask a doctor if

    you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    • take preferably at bedtime or as directed by a doctor
     agestarting dosage maximum dosage 
    adults and children 12 years of age and over2 tablets once a day4 tablets twice a day 
    children 6 to under 12 years1 tablet once a day2 tablets twice a day 
    children 2 to under 6 years1/2 tablet once a day 1 tablet twice a day 
    children under 2 yearsask a doctor ask a doctor 

  • Other information

    • each tablet contains: calcium 30 mg
    • store at 25ºC (77ºF); excursions permitted between 15-30ºC (59-86ºF)
  • Inactive ingredients

    croscarmellose sodium, anhydrous dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, silicon dioxide, talc, triacetin

  • Questions or comments?

    Call 1-833-358-6431 Monday to Friday 9:00am to 7:00pm EST

  • Principal Display Panel

    COMPARE TO SENOKOT® ACTIVE INGREDIENT*

    Senna laxative

    Natural Vegetable Laxative Ingredient

    Gently, overnight relief 

    SENNOSIDES, 8.6 MG

    TABLETS

    *This product is not manufactured or distributed by Avrio Health L.P., distributor of Senokot®.

    TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

    KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.

    Distributed by McKesson Corp.,

    via Strategic Sourcing Services LLC, Memphis, TN 38141

    www.sunmarkbrand.com

  • Product Labeling

    Sennosides 8.6 mg

    SUNMARK Senna Laxative

  • INGREDIENTS AND APPEARANCE
    SENNA LAXATIVE 
    sennosides tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70677-0164
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    TALC (UNII: 7SEV7J4R1U)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    TRIACETIN (UNII: XHX3C3X673)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Product Characteristics
    ColorbrownScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code PS23
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70677-0164-11 in 1 BOX08/01/2022
    1100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00708/01/2022
    Labeler - Strategic Sourcing Services LLC (116956644)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!